External And Internal Convergence - A Cross-Sector Approach To Healthcare’s Biggest Challenges


As health economies face challenges of improving outcomes while lowering cost, among many others, a cross sector approach to health and care is vital.

Alongside new bio technologies and combination therapeutic approaches has come the rapid expansion of AI in multiple settings, new digital technologies and, importantly, the more tech-savvy and engaged patient, convergence is starting to make meaningful impacts.

How is the industry developing new core digital capabilities, alliances, partnerships and innovative ways to drive better outcomes?

  • In which ways are health and care industry leaders’ driving solutions to healthcare’s biggest challenges through different therapeutics, digital, and device combination approaches?
  • To what extent does external innovation fit into this picture for pharma companies like J&J?
  • How can the industry work towards true & meaningful convergence to improve outcomes?
  • How can this holistic approach and personalised medicine approaches go hand in hand?
Melanie Senior, Writer and Analyst (moderator)
Prabhu Velusami, Senior Director, New Ventures and Transactions, Johnson & Johnson
Dan Vahdat, CEO, Huma
Nikolaj Sorensen, CEO, Orexo
Jackie Hunter, Board Director, BenevolentAI

This session was delivered as part of the Investival Showcase 2020. Find out about the full event by downloading the brochure.